Acetaminophen
- Generic Name
- Acetaminophen
- Brand Names
- Acephen, Acetadryl, Allzital, Apadaz, Arthriten Inflammatory Pain, Bupap, Butapap, Cetafen, Children's Silapap, Coricidin Hbp Cold & Flu, Darvocet-N, Dayquil Sinex, Diphen, Dolofin, Dologen, Dologesic Reformulated Jun 2016, Duralgina, Dvorah, Endocet, Esgic, Exaprin, Excedrin, Excedrin PM Triple Action, Excedrin Tension Headache, Feverall, Fioricet, Fioricet With Codeine, Goody's Back & Body Pain Relief, Goody's Body Pain, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Hycet, Legatrin PM, Little Fevers, Lorcet, Lortab, Mapap, Mersyndol, Midol Complete, Midol Cramps & Bodyaches, Nalocet, Norco, Orbivan, Pamprin Max Formula, Pamprin Multi-symptom, Panadol, Pediacare Children's Fever Reducer Pain Reliever, Percocet, Percogesic Reformulated Jan 2011, Pharbetol, Premsyn Pms, Prolate, Rivacocet, Robaxacet, Robaxacet-8, Roxicet, Sudafed PE Sinus Headache, Tactinal, Tencon, Trezix, Triatec, Triatec-30, Triatec-8, Tylenol, Tylenol PM, Tylenol With Codeine, Ultracet, Vanatol, Vanatol S, Vanquish, Xodol, Xolox, Zamicet, Zflex, Zydone
- Drug Type
- Small Molecule
- Chemical Formula
- C8H9NO2
- CAS Number
- 103-90-2
- Unique Ingredient Identifier
- 362O9ITL9D
- Background
Acetaminophen (paracetamol), also commonly known as Tylenol, is the most commonly taken analgesic worldwide and is recommended as first-line therapy in pain conditions by the World Health Organization (WHO). It is also used for its antipyretic effects, helping to reduce fever. This drug was initially approved by the U.S. FDA in 1951 and is available in a var...
- Indication
In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms.
...
- Associated Conditions
- Acute Gouty Arthritis, Acute Musculoskeletal Pain, Allergic Reaction, Allergy to Tree Pollen, Ankylosing Spondylitis (AS), Chills, Cold, Common Cold, Cough, Cough caused by Common Cold, Coughing caused by Flu caused by Influenza, Dyskinesia of the Biliary Tract, Dyskinesia of the Urinary Tract, Febrile Convulsions, Febrile Illness Acute, Fever, Fibromyalgia, Flu caused by Influenza, Headache, Joint dislocations, Menstrual Distress (Dysmenorrhea), Mild pain, Muscle Inflammation, Muscle Injuries, Muscle Spasms, Musculoskeletal Pain, Myalgia, Nasal Congestion, Neuropathic Pain, Osteoarthritis (OA), Pain, Postoperative pain, Premenstrual cramps, Rheumatoid Arthritis, Rhinopharyngitis, Rhinorrhoea, Severe Pain, Sinusitis, Spasms, Spastic Pain of the Gastrointestinal Tract, Sprains, Symptoms Cold, Tension Headache, Toothache, Upper Respiratory Tract Infection, Whiplash Syndrome, Acute Torticollis, Articular inflammation, Cold or flu syndrome, Mild to moderate pain, Minor aches and pains, Minor pain, Moderate Pain, Moderate to severe pain
- Associated Therapies
- Airway secretion clearance therapy, Anti-spasmodics, Bronchodilation
Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus
- Conditions
- Interventions
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 56
- Registration Number
- NCT06152796
Effect of Acetaminophen Versus Ibuprofen in Treating Recurrent Apthous Ulcers in Pediatric Celiac Disease
- Conditions
- Interventions
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2023-12-28
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 12
- Registration Number
- NCT06149507
The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA
- Conditions
- Interventions
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Damascus University
- Target Recruit Count
- 80
- Registration Number
- NCT06112548
- Locations
- 🇸🇾
Damascus university, Damascus, Syrian Arab Republic
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT06109415
- Locations
- 🇺🇸
First Surgical Hospital, Bellaire, Texas, United States
🇺🇸Legent Orthopedic Hospital, Carrollton, Texas, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
- Conditions
- Interventions
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT06109428
- Locations
- 🇺🇸
Endeavor Clinical Trials, LLC, San Antonio, Texas, United States
🇺🇸First Surgical Hospital, Bellaire, Texas, United States
Heamodynamic Effects of Paracetamol in Septic Shock Patients
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- Ayah Mohammed Khalil
- Target Recruit Count
- 61
- Registration Number
- NCT06076980
- Locations
- 🇪🇬
Cairo University hospitals, Cairo, Egypt
Comparison of the Efficacy of Paracetamol and Ibuprofen in the Management of Fever in Sepsis Patients
- Conditions
- Interventions
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- Ankara City Hospital Bilkent
- Target Recruit Count
- 84
- Registration Number
- NCT06061575
- Locations
- 🇹🇷
Ankara City Hospital, Ankara, Turkey
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination with Radiotherapy (RT) in Relapsed/refractory Follicular Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06043323
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
- Conditions
- Interventions
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 18
- Registration Number
- NCT06019728
- Locations
- 🇺🇸
Emory University School of Medicine Site Number : 1005, Atlanta, Georgia, United States
🇺🇸Lysosomal and Rare Disorders Research and Treatment Center, Inc Site Number : 1002, Fairfax, Virginia, United States
🇺🇸Infusion Associates Site Number : 1001, Grand Rapids, Michigan, United States
Evaluation of Apraglutide on Gastric Emptying
- Conditions
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- VectivBio AG
- Target Recruit Count
- 42
- Registration Number
- NCT05995704
- Locations
- 🇳🇱
ICON Clinical Research Unit, Groningen, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.